Urinary Incontinence Market: Global Key Players are - NeoTract, Inc, Promedon, Cook Medical Inc., C.R. Bard Inc., Coloplast Corp, Boston Scientific Corporation

Market Research Future published a cooked research report on “Urinary Incontinence Market Research Report - Forecast till 2022”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

Urinary incontinence is the knee-jerk leakage of urine, it is also known as involuntary urination. It is an awkward situation where leakage of urine create embarrassing situation in public. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, women were more likely to suffer with the urinary incontinence in comparison to men. Statistics shows that women accounts 1.2 times more episode of urinary incontinence than men. Sudden extra presser on bladder and muscles involved in urinary control leads the urinary incontinence episode.

The global urinary incontinence market is showing average growth; mainly due to increase in obesity population, urinary tract infection, and high consumption of alcohol. There are incidences reported where stress causes the urinary incontinence. Urinary incontinency is a result of a number of diseases like polyuria, prostate cancer, enlarged prostate, Parkinson’s disease, multiple sclerosis, spinal cord injury, and many more. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 50.9% of persons aged 65 year reported a urinary leakage or accidental bowel leakage. According to the Urology Care Foundation, in 2015, quarter to a third of men and women in the United States were suffering from involuntary urination. Millions of the Americans are facing the problems of involuntary urination and about 33 million have overactive bladder representing symptoms of urgency, frequency and with or without urge incontinence.

Get a sample report at https://www.marketresearchfuture.com/sample_request/1097 .

Companies are showing much interest toward the market of involuntary urination, as they feels there are huge opportunity and gap between the market demand and supply of effective treatments. Thus, companies are showing more interest in merger and acquisition activities for introducing best cure that meet the requirement of the market. The development has been made by Boston Scientific Corporation in 2015, where they announced the agreement with Endo International plc. to acquire American Medical Systems’ urology portfolio, for cementing the global leadership position in the urology devices and provide strong treatment options in the market. This agreement includes the buying rights for men's health and prostate health businesses, for $1.6 billion in up-front cash and a potential additional $50 million milestone based on 2016 sales. This acquisition will leads to innovation in better way and help them to compete there competitor with more effective manner. Boston Scientific Corporation try to feel the gap along with market players such as Ethicon Inc., Coloplast Corp, C. R. Bard, Inc.,  Promedon, NeoTract, Inc., ConvaTec Group plc, Procter & Gamble Co., and Marlen Manufacturing.

Increasing in the prevalence of urinary incontinence around the globe is creating the huge scope for the market players to make profit. There are three drugs that accounts 80% of prescribe volume, these includes solifenacin, oxybutynin, and tolterodine. Solifenacin capture 37% of prescribe volume followed by 28% by oxybutynin, and tolterodine capture 18% of the market.

Ethicon Inc. (U.S.), Boston Scientific Corporation (U.S.), Coloplast Corp (Europe), C. R. Bard, Inc. (U.S.), Promedon (U.S.), NeoTract, Inc. (U.S.), ConvaTec Group plc. (Europe), Procter & Gamble Co. (U.S.), and Marlen Manufacturing (U.S.) are some of the leading players at the cutting edge of the competition in the market of urinary incontinence market, globally.

Browse Complete Report at https://www.marketresearchfuture.com/reports/urinary-incontinence-market-1097 .

Global Urinary Incontinence Market   - Regional Analysis

The market of urinary incontinence drugs is much higher in Asia Pacific region, owing to obesity population, high consumption of alcohol, consumption of spicy foods, and large doses of vitamin C. These are the factors which fuels the urinary incontinence drugs market in this region. Most of the countries of this region have common lifestyle and economic conditions and are focusing more to enhance the treatment option. Thus, more research and development programs are initiated for the development of new drugs. Government of developing countries within this region are willing to adopt advanced treatment option available in developed countries, which fuel the market of urinary incontinence. These advance drugs will overcome the saturation that occurs during last few years. Countries like India and china are more focused market for global market players owing to huge patient population and growing purchasing power as compare to other countries in this region. Japan is well developed country and have advanced healthcare system and technology, whereas developing countries are still focusing on new drugs and technology for the treatment of urinary incontinence patients, the unmet market needs has to be fulfilled by introducing advanced and better treatment options.

About us

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

P: +1 646 845 9312

W: www.marketresearchfuture.com

sales@marketresearchfuture.com

This release was published on openPR.